Pharma Packaging and Logistics
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Eli Lilly and Company and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines for the treatment of...
$149 a month new oral GLP-1 pill for weight loss (Foundayo (orforglipron)) now available in the US
Eli Lilly and Company has announced that Foundayo™ (orforglipron) is now available to adults with obesity or overweight with weight-related...
European Commission approves Kygevvi (doxecitine and doxribtimine) as first and only treatment for thymidine kinase 2 deficiency
UCB, a global biopharmaceutical company, has announced that the European Commission (EC) has granted marketing authorisation under exceptional circumstances...
Romaco Group appoints Nicola Magriotis as Chief Sales Officer
The advisory board of Romaco Holding GmbH has appointed Nicola Magriotis as Chief Sales Officer (CSO) of the Romaco...
New report finds FDA costs soaring and drug rejections rising
The Taxpayers Protection Alliance released a report, called Blocking Breakthroughs: Delays and Denials at the FDA, that highlights the many issues...
Eisai and Nuvation Bio announce marketing authorisation application for taletrectinib for the treatment of advanced ROS1-positive non-small cell lung cancer validated by the European...
Eisai Co, a human-centred global leading research-based pharmaceutical company working in the neurology and oncology therapeutic areas, and Nuvation...
Ellison purchase swells triangle’s lab space
Oxfordshire, a key part of UK life sciences’ Golden Triangle region, had an annual take-up of lab space last...
Inaugural International Brain Health Conference 2026 to focus on early intervention before dementia
International Brain Health Conference 2026 18–19 May 2026 Sheraton Grand Hotel, Edinburgh, UK
An international conference bringing together global leaders in neuroscience,...
Seda accelerates global pharma growth with £15m backing from BGF
BGF, the UK and Ireland’s most active growth capital investor, has completed a £15 million investment in Seda Pharma Development...
Enzymatica and STADA sign partnership agreement for Germany and Austria
Enzymatica AB and STADA Arzneimittel AG have entered into a partnership agreement regarding the launch and distribution of Enzymatica’s...
Cambridge’s grassroots life sciences showcase branches out to Oxford and London
Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival...
FDA approves Novo Nordisk’s Awiqli, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
The US Food and Drug Administration (FDA) has approved Novo Nordisk's Awiqli® (insulin icodec-abae) injection 700 units/mL, the first and...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Popular
© 2026 Pharma Press Publishing.